{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:50:32Z","timestamp":1792799432594,"version":"4.5.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec>\n                    <jats:title>CONTEXT:<\/jats:title>\n                    <jats:p>\n                      Ventilator-associated pneumonia (VAP) develops nearly in about one-third of the patients, 48 h after receiving mechanical ventilation. Common pathogens are\n                      <jats:italic toggle=\"yes\">Pseudomonas aeruginosa,<\/jats:italic>\n                      <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">Acinetobacter<\/jats:italic>\n                      spp.,\n                      <jats:italic toggle=\"yes\">Klebsiella<\/jats:italic>\n                      spp.,\n                      <jats:italic toggle=\"yes\">Escherichia coli,<\/jats:italic>\n                      <jats:italic toggle=\"yes\">Proteus<\/jats:italic>\n                      spp.,\n                      <jats:italic toggle=\"yes\">Enterobacter<\/jats:italic>\n                      spp. and\n                      <jats:italic toggle=\"yes\">Enterococcus<\/jats:italic>\n                      spp. including multidrug-resistant pathogens.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>AIM:<\/jats:title>\n                    <jats:p>The study aims to assess the pattern of antimicrobial drug use in VAP and to assess the etiological organisms and their drug sensitivity and resistance pattern.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SETTINGS AND DESIGN:<\/jats:title>\n                    <jats:p>Study participants admitted to Kempegowda Institute of Medical Sciences Hospital and Research Centre, Bengaluru, and who developed VAP were included in this prospective observational study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SUBJECTS AND METHODS:<\/jats:title>\n                    <jats:p>Bronchial secretions were subjected to microbiological analysis. The etiological organisms, their drug sensitivity and resistance pattern, and the outcome of drug therapy were recorded. The clinical course of the study participants was monitored till either the resolution of pneumonia or the demise of the participant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STATISTICAL ANALYSIS USED:<\/jats:title>\n                    <jats:p>\n                      Qualitative data were analyzed using the Chi-square test or Fischer's exact test and quantitative data using the independent\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -test.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Early VAP was seen in 91.7% and late VAP in 8.3% of the participants. The organisms isolated were\n                      <jats:italic toggle=\"yes\">S. aureus<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">Enterococcus<\/jats:italic>\n                      spp.,\n                      <jats:italic toggle=\"yes\">Acinetobacter<\/jats:italic>\n                      spp.,\n                      <jats:italic toggle=\"yes\">Klebsiella pneumoniae<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">P. aeruginosa<\/jats:italic>\n                      . Majority of the study participants with early VAP (75%,\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 41) completely recovered from pneumonia and 80%,\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 4 participants with late VAP recovered completely.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>The organisms had a varied sensitivity and resistance pattern. The clinical outcome was multifactorial and its association with specific antimicrobial agents cannot be drawn.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijp.ijp_759_21","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T16:01:29Z","timestamp":1716480089000},"page":"89-96","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["A clinical study on the pattern of antimicrobial drug use and drug resistance in patients with ventilator-associated pneumonia in a tertiary care hospital"],"prefix":"10.4103","volume":"55","author":[{"given":"Abisha","family":"Rezia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Vijendra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-3-20240903","doi-asserted-by":"crossref","first-page":"2061.1","DOI":"10.12688\/f1000research.12222.1","article-title":"Update on ventilator-associated pneumonia","volume":"6","author":"Timsit","year":"2017","journal-title":"F1000Res"},{"key":"R3-3-20240903","doi-asserted-by":"crossref","first-page":"185S","DOI":"10.1016\/0002-9343(91)90367-7","article-title":"Nosocomial infection rates in adult and pediatric intensive care units in the United States. National nosocomial infections surveillance system","volume":"91","author":"Jarvis","year":"1991","journal-title":"Am J Med"},{"key":"R4-3-20240903","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3201\/eid0702.010202","article-title":"Infection control and changing health-care delivery systems","volume":"7","author":"Jarvis","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"R5-3-20240903","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1086\/501795","article-title":"Nosocomial infections in combined medical-surgical intensive care units in the United States","volume":"21","author":"Richards","year":"2000","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R6-3-20240903","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1378\/chest.120.6.2059","article-title":"Infection control in the ICU","volume":"120","author":"Eggimann","year":"2001","journal-title":"Chest"},{"key":"R8-3-20240903","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S1473-3099(17)30396-1","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: A systematic analysis for the global burden of disease study 2015","volume":"17","author":"Troeger","year":"2017","journal-title":"Lancet Inf Dis"},{"key":"R10-3-20240903","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s13312-017-1151-x","article-title":"Revised Kuppuswamy's socioeconomic status scale: Explained and updated","volume":"54","author":"Sharma","year":"2017","journal-title":"Indian Pediatr"},{"key":"R12-3-20240903","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.12659\/MSM.905919","article-title":"Prognostic risk factors in ventilator-associated pneumonia","volume":"24","author":"Karakuzu","year":"2018","journal-title":"Med Sci Monit"},{"key":"R13-3-20240903","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2147\/IDR.S67267","article-title":"Microbiology, resistance patterns, and risk factors of mortality in ventilator-associated bacterial pneumonia in a Northern Thai tertiary-care university based general surgical intensive care unit","volume":"7","author":"Chittawatanarat","year":"2014","journal-title":"Infect Drug Resist"},{"key":"R14-3-20240903","doi-asserted-by":"crossref","first-page":"8231787","DOI":"10.1155\/2016\/8231787","article-title":"Epidemiology and outcome of ventilator-associated pneumonia in a heterogeneous ICU population in Qatar","volume":"2016","author":"Ali","year":"2016","journal-title":"Biomed Res Int"},{"key":"R15-3-20240903","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s12879-017-2529-z","article-title":"Patterns of antimicrobial resistance in intensive care unit patients: A study in Vietnam","volume":"17","author":"Tran","year":"2017","journal-title":"BMC Infect Dis"},{"key":"R16-3-20240903","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.4187\/respcare.02173","article-title":"Comparison of the bacterial etiology of early-onset and late-onset ventilator-associated pneumonia in subjects enrolled in 2 large clinical studies","volume":"58","author":"Restrepo","year":"2013","journal-title":"Respir Care"},{"key":"R17-3-20240903","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4103\/0976-0105.118797","article-title":"Antimicrobial resistance pattern in a tertiary care hospital: An observational study","volume":"4","author":"Saravanan","year":"2013","journal-title":"J Basic Clin Pharm"},{"key":"R18-3-20240903","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4066\/AMJ.2013.1710","article-title":"Aetiological agents of ventilator-associated pneumonia and its resistance pattern \u2013 A threat for treatment","volume":"6","author":"Charles","year":"2013","journal-title":"Australas Med J"},{"key":"R19-3-20240903","first-page":"2462","article-title":"Microbial profile of early and late onset ventilator associated pneumonia in the intensive care unit of a tertiary care hospital in Bangalore, India","volume":"7","author":"Golia","year":"2013","journal-title":"J Clin Diagn Res"},{"key":"R20-3-20240903","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4103\/0976-9668.198360","article-title":"Incidence, bacteriology, and clinical outcome of ventilator-associated pneumonia at tertiary care hospital","volume":"8","author":"Patil","year":"2017","journal-title":"J Nat Sci Biol Med"},{"key":"R21-3-20240903","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3855\/jidc.634","article-title":"Ventilator-associated pneumonia in a tertiary care hospital in India: Role of multi-drug resistant pathogens","volume":"4","author":"Joseph","year":"2010","journal-title":"J Infect Dev Ctries"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.ijp_759_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:46:10Z","timestamp":1787769970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.ijp_759_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijp.ijp_759_21","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]}}}